Vaxxas

0 followers

‌

Needle-free vaccination and vaccine delivery solutions that safely and cost effectively amplify vaccine efficacy using Nanopatch technology developed by Vaxxas.

Headquarters

Sydney, Australia

Employees

51-200

Links

Org chart

David Hoey

Collapse
Tom Lake
Senior Vice President
Angus Forster
Chief Technology Officer
Michael Junger
Director - Industry And Government Relations
Charlotte Sweeney
Head of Formulation & Analytical
Damien Colbert
Head Of People And Performance
Deborah Pascoe, PhD
Head Of Early Stage And RNA Programs
Doug Cubbin
Chief Financial Officer
Paul Fahey
Head of Formulation & Analytical
Sarika Namjoshi, PhD
Head of Formulation and Analytical
Scott Fry
Chief Operating Officer
Dan Devine
Chief Business Officer/General Counsel/EVP
Kevin Black, CPA, MBA
Head, Special Projects
Michael Larcom
Senior Vice President of Quality